Literature DB >> 28803566

The pyogenic potential of the different Streptococcus anginosus group bacterial species: retrospective cohort study.

O Kobo1, S Nikola2, Y Geffen3, M Paul2.   

Abstract

Streptococcus anginosus Group (SAG) bacteria are common causes of pyogenic infections (PIs). We examined the association between SAG species and the presence of a PI through a retrospective, observational, cohort study, between the years 2009 and 2015. All adults with clinically significant SAG infections in one hospital in Israel were assessed for association between SAG species and the presence of a PI defined as an abscess, empyema, or deep/organ space surgical site infection. Risk factors for PI were assessed using multivariate backward stepwise logistic regression analysis. We identified 263 patients with significant SAG infections, 182 (69%) of which were caused by S. anginosus, 45 (17·1%) by S treptococcus constellatus and 36 (13·7%) by S treptococcus intermedius. The mean age of the patients was 56·8 ± 19·1 years. PIs were identified among 160 (60%) of the patients and were mostly non-bacteraemic (147/160, 91·8%), while most non-PI patients had bacteraemia (70/103, 68%). S. anginosus and S. constellatus were associated with a significantly lower incidence of PI than S. intermedius, OR 0·18 (95% CI 0·06-0·53) and 0·14 (0·04-0·48), respectively. Patients with PI were younger and, in general, had less co-morbidities. S. intermedius was associated with pyogenic non-bacteraemic infections, while S. anginosus and S. constellatus were associated with bacteraemia with no abscess or empyema formation. These data may indicate differences in virulence mechanisms of these SAG bacteria.

Entities:  

Keywords:  zzm321990 Streptococcus anginosus Group; Pyogenic infections

Mesh:

Year:  2017        PMID: 28803566      PMCID: PMC9152745          DOI: 10.1017/S0950268817001807

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  13 in total

1.  Performance of the new VITEK 2 GP card for identification of medically relevant gram-positive cocci in a routine clinical laboratory.

Authors:  Guido Funke; Pascale Funke-Kissling
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

2.  Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by use of VITEK 2.

Authors:  Marjo Haanperä; Jari Jalava; Pentti Huovinen; Olli Meurman; Kaisu Rantakokko-Jalava
Journal:  J Clin Microbiol       Date:  2007-01-10       Impact factor: 5.948

3.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

Review 4.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

5.  Milleri group streptococcus--a stepchild in the viridans family.

Authors:  Y Siegman-Igra; Y Azmon; D Schwartz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-06       Impact factor: 3.267

6.  Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus ("Streptococcus milleri group") are of different clinical importance and are not equally associated with abscess.

Authors:  J E Claridge; S Attorri; D M Musher; J Hebert; S Dunbar
Journal:  Clin Infect Dis       Date:  2001-04-20       Impact factor: 9.079

Review 7.  Streptococcus anginosus group disseminated infection: case report and review of literature.

Authors:  Simone Giuliano; Giuliano Simone; Giorgia Rubini; Andrea Conte; Andrea Conti; Paola Goldoni; Marco Falcone; Antonio Vena; Mario Venditti; Sergio Morelli
Journal:  Infez Med       Date:  2012-09

8.  LacR mutations are frequently observed in Streptococcus intermedius and are responsible for increased intermedilysin production and virulence.

Authors:  Toshifumi Tomoyasu; Hidenori Imaki; Sachiko Masuda; Ayumi Okamoto; Hyejin Kim; Richard D Waite; Robert A Whiley; Ken Kikuchi; Keiichi Hiramatsu; Atsushi Tabata; Hideaki Nagamune
Journal:  Infect Immun       Date:  2013-06-24       Impact factor: 3.441

9.  Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region.

Authors:  K B Laupland; T Ross; D L Church; D B Gregson
Journal:  Clin Microbiol Infect       Date:  2006-03       Impact factor: 8.067

Review 10.  Occurrence and pathogenicity of the Streptococcus milleri group.

Authors:  J Gossling
Journal:  Rev Infect Dis       Date:  1988 Mar-Apr
View more
  12 in total

1.  The Role of SilX in Bacteriocin Production of Streptococcus anginosus.

Authors:  Verena Vogel; Miki Fuchs; Marie Jachmann; Alina Bitzer; Stefanie Mauerer; Jan Münch; Barbara Spellerberg
Journal:  Front Microbiol       Date:  2022-07-01       Impact factor: 6.064

Review 2.  From Normal Flora to Brain Abscesses: A Review of Streptococcus intermedius.

Authors:  Elio Issa; Tamara Salloum; Sima Tokajian
Journal:  Front Microbiol       Date:  2020-05-07       Impact factor: 5.640

3.  Angicin, a novel bacteriocin of Streptococcus anginosus.

Authors:  Verena Vogel; Richard Bauer; Stefanie Mauerer; Nicole Schiffelholz; Christian Haupt; Gerd M Seibold; Marcus Fändrich; Paul Walther; Barbara Spellerberg
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

4.  Regulation of the β-hemolysin gene cluster of Streptococcus anginosus by CcpA.

Authors:  Richard Bauer; Stefanie Mauerer; Barbara Spellerberg
Journal:  Sci Rep       Date:  2018-06-13       Impact factor: 4.379

5.  Streptococcus constellatus Causing Empyema and Sepsis, Necessitating Early Surgical Decortication.

Authors:  D Chrastek; S Hickman; D Sitaranjan; I Vokshi; O Kakisi; J Kadlec; W Bartosik; F Van Tornout; V Kouritas
Journal:  Case Rep Infect Dis       Date:  2020-07-12

Review 6.  [Pelvic inflammatory disease by Streptococcus constellatus. Clinical experience and a review].

Authors:  J C Mora-Palma; V Guillot-Suay; M M Sánchez Gila; J Gutiérrez-Fernández
Journal:  Rev Esp Quimioter       Date:  2020-06-09       Impact factor: 1.553

7.  COMPLICATED PNEUMONIA WITH EMPYEMA CAUSED BY STREPTOCOCCUS ANGINOSUS IN A CHILD.

Authors:  Ana Reis-Melo; Diana Soares; Manuel Ferreira Magalhães; Catarina Ferraz; Luísa Vaz
Journal:  Rev Paul Pediatr       Date:  2020-03-09

8.  Antimicrobial resistance of bacteraemia in the emergency department of a German university hospital (2013-2018): potential carbapenem-sparing empiric treatment options in light of the new EUCAST recommendations.

Authors:  Kathrin Rothe; Nina Wantia; Christoph D Spinner; Jochen Schneider; Tobias Lahmer; Birgit Waschulzik; Roland M Schmid; Dirk H Busch; Juri Katchanov
Journal:  BMC Infect Dis       Date:  2019-12-30       Impact factor: 3.090

9.  A diagnostic algorithm for detection of urinary tract infections in hospitalized patients with bacteriuria: The "Triple F" approach supported by Procalcitonin and paired blood and urine cultures.

Authors:  Kathrin Rothe; Christoph D Spinner; Birgit Waschulzik; Christian Janke; Jochen Schneider; Heike Schneider; Krischan Braitsch; Christopher Smith; Roland M Schmid; Dirk H Busch; Juri Katchanov
Journal:  PLoS One       Date:  2020-10-22       Impact factor: 3.240

10.  Streptococcus anginosus and Phalangeal Osteomyelitis: An Unusual Presentation.

Authors:  Luís Mata Ribeiro; Sara Carvalho; Diogo Guimarães; Manuel Vilela; Ana S Guerra
Journal:  J Orthop Case Rep       Date:  2020-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.